18d10b1f-3e43-4c73-a685-3090c000628b
Identification of new molecular mechanisms potentially involved in the development of Parkinson's disease.Modeling early Parkinson's disease pathology with chronic low dose MPTP treatment.Cell-replacement and gene-therapy strategies for Parkinson's and Alzheimer's diseaseRepulsive guidance molecule a (RGMa) induces neuropathological and behavioral changes that closely resemble Parkinson's diseaseSmall Scale Production of Recombinant Adeno-Associated Viral Vectors for Gene Delivery to the Nervous SystemComparison of AAV serotypes for gene delivery to dopaminergic neurons in the substantia nigra.The proliferative capacity of the subventricular zone is maintained in the parkinsonian brain.Reply: Quantitative evaluation of the human subventricular zone.Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling.